Stock Ratings / Consumer Discretionary / CL

ECL (71) UL (65) EL (57) HLN (55) ⌘ Pro Terminal →

Colgate-Palmolive Company (CL) — RQD Stock Rating Cockpit

$95.29 +2.29% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $95.91

Colgate-Palmolive Company (CL) earns a Roarable Rating of B- (Buy) with 70/100 RQD Confidence. High-quality cash engine (60% profit margin, 44% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

📊 Historical Track Record: Scores of 70/100 (B-) historically ranked in the Top 15% of excess returns over the next 90 days (+6.6% avg 90D alpha vs SPY • 68.1% hit rate) →

ROARABLE B- • BUY Cap $74.26B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on CL Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is CL stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-02, Colgate-Palmolive Company (NYSE: CL) is rated B- (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 70/100 at a spot price of $95.29 (+2.29% 1D, market cap $74.26B). Pillar breakdown: Fundamental Cash Engine 19/20, Institutional 13F & Options Flow 15/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 9/20, and SEC Balance-Sheet Forensics 14/20. Across 1011 tracked Consumer Discretionary issuers, CL ranks #143 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does CL compare to ECL and UL in the Consumer Discretionary sector?

▼

Within the Consumer Discretionary sector (Package Goods/Cosmetics), CL carries a Roarable B- (70/100 RQD), trailing P/E of 34.8x, gross margin of 60.1%, and ROIC of 44.0%. By comparison, ECL (Ecolab Inc.) holds a B- grade (71/100 RQD, P/E 40.6x, ROIC 14.1%, cap $84.34B) and UL (Unilever PLC American) posts a C grade (65/100 RQD, P/E 32.8x, ROIC 9.9%, cap $138.26B). Among the 5-stock peer group, UL leads on earnings multiple (32.8x) while CL leads on capital efficiency (44.0% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for CL?

▼

Per CL's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000021665), Colgate-Palmolive Company generated $20.38B in revenue (+1.4% YoY), $2.13B in net income, and $3.28B in free cash flow against $16.33B in total assets and $6.87B in total debt. Key quantitative strengths: Strong cash generator (60% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $95.91 (+0.65%)🧬 Cannibal Buyback (-1.80% YoY Shares)⚙️ Cash Engine: 19/20 (A+) • 16.1% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 70/100 (B-) historically ranked in the Top 15% of excess returns over the next 90 days (+6.6% avg 90D alpha vs SPY • 68.1% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERBUY • B-

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B+ · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE+5.4% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for CL)Realized 20D OHLCV Swing Band: ±4.2%

Deterministic 5-Pillar Attribution (70/100 Composite)

🔍 WHY CL SCORES 70/100 (B-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Cash Engine Quality+19/20 pts (27% of score)

SEC XBRL FY 2025 (10-K): 16.1% FCF Margin ($3.28B FCF) & 60.1% Gross Margin

▲ #2 Bullish Driver: Whale & Options Positioning+15/20 pts (21% of score)

20D Institutional Volume Accumulation (±4.2% realized swing band)

▼ #1 Drag / Risk Factor: Macro Regime Fit9/20 pts (-11 pt drag)

Macro rate sensitivity & RSI-14 (54.7) create a -11 pt regime headwind

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C+$89.95+5.1% Next Q

Q2 (-2Q)

Grade C+$94.54-2.5% Next Q

Q3 (-1Q)

Grade B-$92.17+3.4% Next Q

Current

Grade B-$95.29+6.6% Hist 90D α

Trajectory: C+ (62) → B- (70)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the CL Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 70/100 (B-) score, CL faces multiple-compression risk if 34.8x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Sensitive to high interest rates and tighter Federal Reserve market liquidity.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-1.80% YoY Shares) — any gross margin slip below 57.6% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($89.61) or 200D SMA ($89.77) invalidates the momentum regime and cuts Target Base ($100.44) toward Bear Floor ($78.14).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $CL• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “CL Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 70%NO 30%Trade / Inspect Odds →

RSI-14 MOMENTUMNEUTRAL RANGE

54.730 Oversold · 70 Hot

ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)

6.90>3.0 Fortress Safe

PIOTROSKI F-SCORESOLID CORE (5–6)

5 / 99-Pt Accounting

52-WEEK LASER RANGE84% OF RANGE

L: $75$95.29H: $99

1. Money & Cash Health● HEALTHY

Are profits real cash in the bank?

Real cash coming in backs up reported profits (60% profit margin and healthy balance-sheet cushion).

Factor Grade: A+RQD 19 / 20

2. Big Money & Insiders● BUYING

Are whales & executives buying or selling?

Hedge funds and options traders are leaning bullish, showing strong institutional appetite.

Factor Grade: BRQD 29 / 40

3. Hidden Risks & Market Weather● WATCH

SEC fine-print scan & interest-rate fit

No major SEC filing blowups, though current interest rates and Fed liquidity call for normal position sizing.

Factor Grade: D+RQD 22 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

JEV AI Jury Split (Battleground) on CL

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

BULLISH (95)

44.0% ROIC with 60.1% gross margin and 4.42% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

NEUTRAL (65)

Altman-Z 6.90 and Piotroski 5/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

NEUTRAL (63)

29/40 institutional & smart-money positioning score with 9/20 macro alignment.

Bull Case: Why Buyers Like CL

✓Strong cash generator (60% profit margin)—profits are backed by real money, not accounting tricks.
✓Big institutional funds and options desks are actively positioning on the bullish side.
✓Company leadership has skin in the game with net positive insider conviction.

Bear Case: What Could Go Wrong

!Sensitive to high interest rates and tighter Federal Reserve market liquidity.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (CL Tape Review)

✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
✓Forensic Red-Light accounting & dilution traps to review on your watchlist
✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

CL // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +11.62%📐 HORIZONTAL RANGE

2026-11-02O $91.69H $95.29L $91.69C $95.29VOL 4.77M

RES: $98.44SUP: $81.68SMA50: $89.61SMA200: $89.77

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

CL Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 CL Butterfly Map → + Track CL →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

26.8%/yr Implied 5Y Growth

vs. +1.4% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on CL today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for CL. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for CL today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CL)

Consumer Discretionary Rank #143 of 1011 ⚔️ ECL vs CL Full Matrix →

1. Head-to-Head Consumer Discretionary Peer Comparison (CL vs. ECL, UL, EL, HLN)

Industry: Package Goods/Cosmetics (23 Tracked Issuers)

Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, Colgate-Palmolive Company (CL) ranks #143 by composite RQD confidence (70/100, grade B-) and #30 by equity capitalization ($74.26B). Within this direct 5-issuer industry benchmark cohort, UL leads on earnings valuation at 32.8x trailing P/E, while CL leads on capital efficiency and profitability with 44.0% ROIC and 60.1% gross margin. ECL currently holds the highest overall quantitative score in the immediate peer group at 71/100 (B-) compared with CL at 70/100 (B-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
CL ACTIVE Colgate-Palmolive Company	B-	70/100	34.8x	60.1%	44.0%	+2.29%	$74.26B	Benchmark Subject
ECL Ecolab Inc.	B-	71/100	40.6x	44.5%	14.1%	+0.71%	$84.34B	/ecl-vs-cl →
UL Unilever PLC American	C	65/100	32.8x	—	9.9%	+1.68%	$138.26B	/ul-vs-cl →
EL Estee Lauder Companies Inc.	D+	57/100	—	74.0%	-11.0%	+0.39%	$39.42B	/el-vs-cl →
HLN Haleon plc American	D+	55/100	32.8x	—	9.9%	+1.05%	$37.69B	/hln-vs-cl →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000021665

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Colgate-Palmolive Company (CL) reported GAAP revenue of $20.38B (+1.4% vs. FY2024 revenue of $20.10B , and +4.8% cumulative change since FY2023) , GAAP net income of $2.13B, operating cash flow of $4.20B, and free cash flow of $3.28B (+2.4% YoY). On the balance sheet, CL closed FY2025 with $16.33B in total assets against $6.87B in total debt (Altman Z-Score: 6.90, Piotroski F-Score: 5/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$20.38B	$2.13B	$4.20B	$3.28B	$16.33B	$6.87B
FY2024 (FY)	2024-12-31	$20.10B	$2.89B	$4.11B	$3.20B	$16.05B	$7.29B
FY2023 (FY)	2023-12-31	$19.46B	$2.30B	$3.75B	$2.87B	$40.85B	$9.56B

3. CL Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is CL stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does CL compare to ECL and UL in the Consumer Discretionary sector?

What are the biggest fundamental strengths and SEC risk factors for CL?

Where is CL trading relative to its 50-day, 200-day, and 52-week technical levels?

CL last traded at $95.29 (+2.29% on volume of 8,839,694 shares), positioning the stock +6.34% above its 50-day simple moving average ($89.61) and +6.15% above its 200-day simple moving average ($89.77). Across its 52-week range of $74.55 to $99.33, CL sits at the 83.7% percentile with a 14-day RSI of 54.7 (NEUTRAL RANGE) and an implied next-earnings move of ±4.2% ($91.29 to $99.29).

CL Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell CL stock right now?

Colgate-Palmolive Company (CL) currently earns a Roarable Rating of B- (Buy — BUY) with 70/100 RQD Confidence. High-quality cash engine (60% profit margin, 44% return on capital) with steady institutional support.

What is CL's 12-month price target and RQD AI Jury consensus?

CL's 12-month base price target is $100.44 (range $78.14 to $118.52), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Direct Sub-Reports: CL RQD Cockpit CL 12M Forecast CL Earnings & Move CL Dividends & DRIP CL Insiders & 13F CL Whale Options CL Profit Sankey CL News & Why

ROARABLE RATING BRIEF • RQD 70/100 (B-) ✓ STAGE-C NUMBER FIREWALL VERIFIED

CL — Colgate-Palmolive Company: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5

As of: 2026-11-02T15:10:24Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, CL scores 70 out of 100, a letter grade of B-, with the verdict label "Roarable Buy — Sound Institutional Accumulation." The five pillars are:

Fundamental Cash Engine: 19 / 20. Per the RQD rating, this reflects ROIC of 44% and an FCF yield of 4.42%. For an investor, this is the strongest pillar and the main source of upside support: high capital efficiency and strong cash generation are the core of the bullish case.
Whale 13F Flow: 15 / 20. Per the RQD rating, this pillar reflects institutional accumulation and options positioning. Institutional support is a positive signal, though the underlying holder detail is not provided in source data.
Insider Conviction: 14 / 20. Per the RQD rating, this pillar reflects SEC Form 4 and Congressional PTR cluster flow. Moderate insider support is noted, but the specific transactions are not itemized in the source data.
Macro Regime Fit: 9 / 20. Per the RQD rating, this pillar reflects Beta of 1.11 and sector sensitivity. This is the weakest pillar and the main valuation and cyclical tradeoff: the stock carries above-market sensitivity to broad moves, and the rating assigns it limited regime alignment.
Forensic Balance Sheet: 13 / 20. Per the RQD rating, this reflects Altman Z of 6.9, Piotroski F of 5/9, and Debt/Equity of 8.5. The Altman Z suggests low distress risk; the Piotroski and leverage figures indicate a mixed balance-sheet picture an investor should weigh.

Taken together, the rating's profile is one of strong cash economics and institutional support, offset by macro sensitivity and a balance sheet that is solid on distress measures but mixed on leverage. Valuation is a central tradeoff: per market data, trailing P/E is 34.8 and forward P/E is 32.4, which are elevated relative to the cash-return metrics above. This is an analytical framing, not personalized advice.

Snapshot

Price	Market Cap	P/E (TTM)	Forward P/E	EV/EBITDA	EPS (TTM)	Dividend Yield	Beta	52-Wk Range	ROIC %
$93.16	$74.26B	34.8	32.4	19.5	2.67	0%	1.11	$74.55 - $99.33	44%

Business

Colgate-Palmolive Company (CL) is a NYSE-listed issuer in the Consumer Discretionary sector, Package Goods/Cosmetics industry, per the company profile. Per the market data, the company reports a gross margin of 60.1%, an operating margin of 16.2%, and a net margin of 10.5%. Specific product lines, customer segments, and revenue-generation mechanics beyond sector and industry classification are not available in source data.

Recent Catalysts & News Wire Analysis

Per the recent news feed, the catalyst and risk-watch items are:

Hill's premium pricing (YELLOW, MARKET WIRE): A Yahoo Finance headline questions whether premium pricing at Hill's can translate into better profits.
International growth (GREEN, CATALYST): A Seeking Alpha headline describes the company's international growth push as working.
Overvaluation risk (RED, RISK WATCH): A 24/7 Wall St. headline questions whether the stock is overvalued and references a "hidden risk" tied to October 30.
Dividend King positioning (YELLOW, MARKET WIRE): A Yahoo Finance headline references hedge fund interest in the stock as a dividend king.
Institutional position increase (YELLOW, MARKET WIRE): A MarketBeat item reports a firm increasing its position in CL.
Q3 beat and outlook raise (GREEN, CATALYST): A Benzinga headline reports a Q3 estimate beat and a raised profit outlook despite weak U.S. demand and rising costs.

The butterfly supply-chain graph lists sector as Consumer Discretionary, industry as Package Goods/Cosmetics, supply chain as NONE, with no butterfly links and no proprietary signals. Per that graph, no supply-chain or proprietary signal data is available.

Butterfly Effect: 2nd-Order Supply-Chain & Sector Ripples

Per the Butterfly Supply-Chain Graph, supply_chain is NONE, butterfly_links is empty, and proprietary_signals is empty. Upstream and downstream dependency mapping is not available in source data. Sector correlation and second-order bottleneck data are not available in source data. From the news wire, the Benzinga headline references weak U.S. demand and rising costs as pressure points an investor may monitor, and the Hill's headline points to premium pricing as a profit lever; beyond these attributed headlines, no further ripple analysis can be supported by source data.

Open Questions

What is the specific composition of institutional 13F holders and options positioning behind the Whale 13F Flow pillar score of 15 / 20?
What are the individual SEC Form 4 and Congressional PTR transactions underlying the Insider Conviction pillar score of 14 / 20?
What EPS figures were reported for FY 2023 through FY 2025, since the source lists EPS as N/A for each period?
What is the cash balance for FY 2023, and what drives the Debt/Equity reading of 8.5 given reported debt figures?
What analyst consensus rating and price targets apply, given that analyst data is not available?

CL Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Colgate-Palmolive Company (CL) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to CL Debate Forum (3) ↓

🟡 MARKET WIRE Yahoo Finance • 6h ago

Colgate-Palmolive (CL): Can Hill’s Turn Premium Pricing Into Better Profits?

Yahoo Finance report covering Colgate-Palmolive Company (CL) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST Seeking Alpha • 9h ago

Colgate-Palmolive: International Growth Push Is Working (NYSE:CL)

Seeking Alpha report covering Colgate-Palmolive Company (CL) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔴 RISK WATCH 24/7 Wall St. • 12h ago

Is This Safe-Haven Stock Overvalued? The Hidden Risk Facing Colgate-Palmolive on Oct. 30

24/7 Wall St. report covering Colgate-Palmolive Company (CL) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 15h ago

Hedge Funds Think Colgate-Palmolive Is One of the Best Dividend King Stocks To Buy

Yahoo Finance report covering Colgate-Palmolive Company (CL) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE MarketBeat • 18h ago

Neville Rodie & Shaw Inc. Increases Stock Position in Colgate-Palmolive Company $CL

MarketBeat report covering Colgate-Palmolive Company (CL) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST Benzinga • 21h ago

Colgate-Palmolive Beats Q3 Estimates, Raises Profit Outlook Despite Weak US Demand, Rising Costs

Benzinga report covering Colgate-Palmolive Company (CL) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST Seeking Alpha • 1d ago

Colgate-Palmolive gains after Q3 sales beat, higher earnings forecast (CL:NYSE)

Seeking Alpha report covering Colgate-Palmolive Company (CL) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST MarketBeat • 1d ago

Colgate-Palmolive Company $CL Stock: First Citizens Bank & Trust Co. Raises Holdings

MarketBeat report covering Colgate-Palmolive Company (CL) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

CL Bull vs. Bear Conversation Board — What's Your Call at $95.29?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON CL 🐻 33% BEARISH CONVICTION

RO RoarDesk_Moderator Roarable Research Desk 🐂 BULLISH 🎯 Target: $109.93 (+18.0%)

📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is CL (B- • RQD 70/100) a Buy at $93.16?

Welcome to the CL (Colgate-Palmolive Company) Roar Pit. Current RQD Composite is 70/100 (Roarable Buy — Sound Institutional Accumulation) in Package Goods/Cosmetics. Bulls point to capital efficiency (44.0% ROIC), while bears focus on valuation multiple compression (34.8x trailing P/E). Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

VA ValDiscipline Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $69.87 (-25.0%)

Spot @ $93.16

Pump the brakes on CL — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on CL, but look at what you are paying: 34.8x trailing P/E with 60.1% gross margins. Unless Colgate-Palmolive Company expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

AL AlphaFlow_Cap Verified K Arena Trader 🐂 BULLISH 🎯 Target: $109.93 (+18.0%)

Spot @ $93.16

CL cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on CL, the market is fixating on short-term headline noise in Package Goods/Cosmetics and ignoring the balance sheet and cash flow trajectory. At $93.16 (52-wk range $74.55 - $99.33), any beat on forward guidance forces shorts and underweight funds to chase.